Takehisa Hanawa Selected Research

Takehisa Hanawa Research Topics

Disease

11	Neoplasms (Cancer) 07/2022 - 04/2002
8	Stomatitis 11/2021 - 04/2002
6	Wounds and Injuries (Trauma) 11/2023 - 10/2018
5	Pain (Aches) 11/2023 - 06/2016
4	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2020
2	Neuralgia (Stump Neuralgia) 01/2023 - 01/2020
2	Feeding and Eating Disorders (Eating Disorder) 12/2016 - 06/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Ototoxicity 10/2022
1	Multiple Sclerosis 08/2022
1	Cerebral Palsy (Spastic Diplegia) 08/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Gram-Positive Bacterial Infections 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Malignant Hypertension 09/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 08/2021
1	Pancreatic Fistula (Pancreatic Fistulas) 02/2021
1	Hyperalgesia 01/2020
1	Stomach Ulcer (Gastric Ulcer) 01/2019
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2019
1	Scabies (Sarcoptic Mange) 04/2017
1	Sleep Wake Disorders 06/2016
1	Hypoalbuminemia 01/2013
1	Chronic Disease (Chronic Diseases) 01/2012
1	Intractable Pain 01/2010
1	Muscle Spasticity (Spastic) 08/2008
1	Pulmonary Hypertension 06/2008
1	Flatulence 08/2007

Drug/Important Bio-Agent (IBA)

4	rebamipideIBA 11/2021 - 08/2017
3	3- (1,3- benzothiazol- 2- yl)- 4- (4- methoxyphenyl)but- 3- enoic acidIBA 12/2021 - 11/2018
2	HydrogelsIBA 11/2023 - 02/2021
2	Tramadol (K315)FDA LinkGeneric 01/2023 - 01/2020
2	Aldehyde Dehydrogenase 1 FamilyIBA 07/2022 - 12/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2018
2	Oral SpraysIBA 01/2018 - 12/2016
2	Allopurinol (Remid)FDA LinkGeneric 02/2004 - 04/2002
1	Carbonated WaterIBA 11/2023
1	AlginatesIBA 11/2023
1	Dosage Forms (Dosage Form)IBA 01/2023
1	Hypromellose DerivativesIBA 01/2023
1	hydrogel filmIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Amikacin (A.M.K)FDA LinkGeneric 10/2022
1	Baclofen FDA LinkGeneric 08/2022
1	Phenobarbital (Luminal)FDA Link 07/2022
1	Small Interfering RNA (siRNA)IBA 07/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Trypan Blue FDA Link 12/2021
1	Protein Kinase CIBA 12/2021
1	Atrial Natriuretic Factor (ANF)IBA 12/2021
1	Clonidine (ST 155)FDA LinkGeneric 09/2021
1	Hypnotics and Sedatives (Sedatives)IBA 09/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2021
1	EnzymesIBA 07/2021
1	Protein Kinases (Protein Kinase)IBA 07/2021
1	Gold Sodium Thiomalate (Sodium Aurothiomalate)IBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	Hyaluronic Acid (Hyaluronan)IBA 03/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021
1	Antimicrobial PeptidesIBA 05/2020
1	AS resinIBA 05/2020
1	Dendrimers (Dendrons)IBA 05/2020
1	Adenosine Monophosphate (AMP)IBA 05/2020
1	GSK 1363089IBA 01/2020
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2020
1	Probenecid (Benemid)FDA LinkGeneric 01/2020
1	Freund's AdjuvantIBA 01/2020
1	UridineIBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	Auranofin (Ridaura)FDA Link 01/2020
1	SolutionsIBA 01/2019
1	OligodeoxyribonucleotidesIBA 10/2018
1	Interleukin-6 (Interleukin 6)IBA 10/2018
1	Ivermectin (Mectizan)FDA Link 04/2017
1	irsogladineIBA 12/2016
1	Antineoplastic Agents (Antineoplastics)IBA 12/2016
1	Ointments (Pastes)IBA 12/2016
1	A-factor (Streptomyces)IBA 06/2016
1	Loperamide (Imodium)FDA LinkGeneric 06/2016
1	xyloglucanIBA 06/2016
1	TeicoplaninIBA 01/2013
1	AlbuminsIBA 01/2013
1	Serum AlbuminIBA 01/2013
1	sarpogrelateIBA 01/2010
1	oxybutynin (Tavor)FDA LinkGeneric 08/2008
1	beraprostIBA 06/2008
1	Fentanyl (Sublimaze)FDA LinkGeneric 08/2007
1	Ropivacaine (Naropin)FDA LinkGeneric 08/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 11/2021 - 04/2002
3	Radiotherapy 01/2019 - 06/2016
2	Oral Administration 01/2018 - 12/2016
2	Therapeutics 08/2008 - 04/2002
1	Anesthesia 09/2021
1	Hemodiafiltration 01/2013
1	Oral Medicine 01/2012
1	Intravesical Administration 08/2008
1	Epidural Analgesia 08/2007